Show
Sort by
-
Disease outcomes and patient’s perspectives after switching biologics from intravenous to subcutaneous administration : a real-world experience in a tertiary IBD-unit
(2024) Abstracts of the 19th Congress of ECCO Stockholm, Sweden, February 21-24, 2024. In Journal of Crohns & Colitis 18(Suppl. 1). p.i2220-i2222 -
The comparative effectiveness and safety of different biologics in young (<60 years) versus elderly (≥60 years) patients with IBD : results from a real-world experience at a Belgian tertiary centre
(2024) Abstracts of the 19th Congress of ECCO Stockholm, Sweden, February 21-24, 2024. In Journal of Crohns & Colitis 18(Suppl. 1). p.i1739-i1740